Department of Histology and Embryology, Medical University of Warsaw, 02-004 Warsaw, Poland.
Laboratory of Experimental Immunology, Military Institute of Hygiene and Epidemiology, 01-163 Warsaw, Poland.
Cells. 2021 Apr 28;10(5):1043. doi: 10.3390/cells10051043.
Mesenchymal stem cells have generated a great deal of interest due to their potential use in regenerative medicine and tissue engineering. Examples illustrating their therapeutic value across various in vivo models are demonstrated in the literature. However, some clinical trials have not proved their therapeutic efficacy, showing that translation into clinical practice is considerably more difficult and discrepancies in clinical protocols can be a source of failure. Among the critical factors which play an important role in MSCs' therapeutic efficiency are the method of preservation of the stem cell viability and various characteristics during their storage and transportation from the GMP production facility to the patient's bedside. The cell storage medium should be considered a key factor stabilizing the environment and greatly influencing cell viability and potency and therefore the effectiveness of advanced therapy medicinal product (ATMP) based on MSCs. In this review, we summarize data from 826 publications concerning the effect of the most frequently used cell preservation solutions on MSC potential as cell-based therapeutic medicinal products.
间充质干细胞因其在再生医学和组织工程中的潜在应用而引起了极大的兴趣。文献中展示了它们在各种体内模型中的治疗价值的例子。然而,一些临床试验并没有证明它们的治疗效果,这表明将其转化为临床实践要困难得多,临床方案中的差异可能是失败的一个原因。在对间充质干细胞治疗效率起着重要作用的关键因素中,有在从 GMP 生产设施到患者床边的储存和运输过程中,保存干细胞活力和各种特性的方法。细胞储存介质应被视为稳定环境的关键因素,对细胞活力和效力有很大影响,因此对基于间充质干细胞的先进治疗药物产品(ATMP)的有效性有很大影响。在这篇综述中,我们总结了 826 篇关于最常用的细胞保存溶液对间充质干细胞作为细胞治疗药物产品的潜力的影响的数据。